Increased Synaptic Dopamine in the Putamen in Restless Legs Syndrome
Increased Synaptic Dopamine in the Putamen in Restless Legs Syndrome
复制标题
DOI:
10.5665/sleep.2300
复制
发表时间:
2013-01-01
期刊:
影响因子:
5.6
通讯作者:
Allen, Richard P.
中科院分区:
文献类型:
--
作者:
Earley, Christopher J.;Kuwabara, Hiroto;Allen, Richard P.
Study Objectives: Prior studies using positron emission tomography (PET) or single-photon emission computed tomography techniques have reported inconsistent findings regarding differences between patients with restless legs syndrome (RLS) and control patients in the striatal dopa-mine- 2 receptor (D2R) binding potentials (BP). D2R-BP does reflect receptor-ligand interactions such as receptor affinity (K-d) and density (beta(max)) or neurotransmitter synaptic concentrations. Thus, differences in D2R-BP reflect changes in these primary factors. PET techniques are currently available to estimate D2R beta(max) and K-d.Design: Separate morning and evening PET scans were performed. The D2R-BP were measured in basal ganglia using [C-11] raclopride.Setting: Academic medical center.Patients or Participants: Thirty-one patients with primary RLS and 36 age-and sex-matched control patients completed the study.Measures and Results: Patients with RLS had lower D2R-BP in putamen and caudate but not the ventral striatum. A subgroups analysis of those RLS patients who had not previously taken dopaminergic medications continued to show a significantly lower D2R-BP in the posterior putamen. D2R-BP did not differ between night and day for either group. D2R beta(max) and K-d did not differ significantly between patients with RLS and control patients but did show a strong and significant increase at night in the ventral striatum. Primary and secondary clinical measures of disease status failed to show any relation to D2R in any brain region.Conclusions: Given the lack of any difference in either beta(max) or K-d and the prior studies supporting an increase in presynaptic dopaminergic activity, the current changes found in D2R-BP likely reflect an increase in synaptic dopamine.